Literature DB >> 6151562

Increase in histidine decarboxylase activity in mouse skin after application of tumor promoters.

Y Kitamura, T Taguchi, M Yokoyama, M Tamai, A Yamatodani, T Watanabe.   

Abstract

The activity of histidine decarboxylase (HDC) increased by a factor of 10 after a single application of 12-O-tetradecanoylphorbol-13-acetate (TPA). The HDC-inducing activity of other phorbol esters paralleled their tumor-promoting activity. Application of some indole alkaloids, which have been shown to be a new class tumor promoter, also induced the increase in HDC activity. The cell type responsible for this increase was examined. First, pieces of the skin were separated into epidermis and dermis after application of TPA. In contrast with ornithine decarboxylase, the HDC activity increased in the dermis. Second, genetically mast cell-deficient W/Wv and Sl/Sld mice were used. Although most histamine in the dermis is in the mast cells, the increase in HDC activity in W/Wv mice was comparable to that in congenic +/+ mice. However, no significant increase in HDC activity was detected in the skin of the Sl/Sld mice. Histological examination revealed that the magnitude of inflammatory cell infiltration was much less in the skin of Sl/Sld mice than in the skin of +/+ or W/Wv mice. The increase in HDC activity and the inflammatory cell response in the skin of W/Wv mice were abolished by prior X-ray irradiation, and were restored by subsequent bone marrow transplantation. Thus, inflammatory cells may be responsible for at least a part of the increase in HDC activity after application of tumor promoters.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6151562

Source DB:  PubMed          Journal:  Princess Takamatsu Symp


  2 in total

1.  Histamine deficiency promotes inflammation-associated carcinogenesis through reduced myeloid maturation and accumulation of CD11b+Ly6G+ immature myeloid cells.

Authors:  Xiang Dong Yang; Walden Ai; Samuel Asfaha; Govind Bhagat; Richard A Friedman; Guangchun Jin; Heuijoon Park; Benjamin Shykind; Thomas G Diacovo; Andras Falus; Timothy C Wang
Journal:  Nat Med       Date:  2010-12-19       Impact factor: 53.440

2.  Palytoxin-induced acute respiratory failure.

Authors:  Lokendra K Thakur; Kunal K Jha
Journal:  Respir Med Case Rep       Date:  2016-10-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.